Edge Wealth Management LLC Roivant Sciences Ltd. Transaction History
Edge Wealth Management LLC
- $472 Million
- Q4 2024
A detailed history of Edge Wealth Management LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Edge Wealth Management LLC holds 90,228 shares of ROIV stock, worth $965,439. This represents 0.23% of its overall portfolio holdings.
Number of Shares
90,228
Previous 90,228
-0.0%
Holding current value
$965,439
Previous $1.04 Million
2.5%
% of portfolio
0.23%
Previous 0.21%
Shares
5 transactions
Others Institutions Holding ROIV
# of Institutions
318Shares Held
508MCall Options Held
1.26MPut Options Held
2.52M-
Sb Investment Advisers (Uk) LTD London, X065.9MShares$705 Million6.27% of portfolio
-
Qvt Financial LP New York, NY65.8MShares$704 Million73.2% of portfolio
-
Viking Global Investors LP54.1MShares$579 Million2.42% of portfolio
-
Vanguard Group Inc Valley Forge, PA41.7MShares$446 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$378 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.54B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...